IL13 and asthma: In this sense, it has been confirmed that G-1 possesses encouraging therapeutic potential for asthma treatment, since it diminished airway hyperresponsiveness and inflammation (decrease in IL-5 and IL-13 levels in bronchoalveolar lavage fluid) in asthma models.